About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Nr3c1tm2.1Ljm
targeted mutation 2.1, Louis J Muglia
MGI:4456461
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Nr3c1tm2.1Ljm/Nr3c1tm2.1Ljm
Lyz2tm1(cre)Ifo/Lyz2+
involves: 129P2/OlaHsd * 129S6/SvEvTac MGI:5803964
cn2
Nr3c1tm2.1Ljm/Nr3c1tm2.1Ljm
Tg(Camk2a-cre)T29-1Stl/0
involves: 129S6/SvEvTac * BALB/c * C57BL MGI:5803966


Genotype
MGI:5803964
cn1
Allelic
Composition
Nr3c1tm2.1Ljm/Nr3c1tm2.1Ljm
Lyz2tm1(cre)Ifo/Lyz2+
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lyz2tm1(cre)Ifo mutation (14 available); any Lyz2 mutation (40 available)
Nr3c1tm2.1Ljm mutation (1 available); any Nr3c1 mutation (35 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• with prior treatment with glucocorticoid stress hormone followed by middle cerebral artery occlusion

hematopoietic system
• prior to glucocorticoid stress hormone treatments fail to exhibit a reduction in numbers of infiltrating monocytes in infarcted hemisphere unlike in wild-type mice

homeostasis/metabolism
• with prior treatment with glucocorticoid stress hormone followed by middle cerebral artery occlusion
• prior treatment with glucocorticoid stress hormone fail to exhibit a reduction in numbers of infiltrating monocytes and IL6 protein levels in infarcted hemisphere after middle cerebral artery occlusion unlike in wild-type mice

immune system
• prior to glucocorticoid stress hormone treatments fail to exhibit a reduction in numbers of infiltrating monocytes in infarcted hemisphere unlike in wild-type mice
• in the ischemic cortex after middle cerebral artery occlusion
• in the hippocampus 12, but not 72, hours after kainic acid treatment
• prior treatment with glucocorticoid stress hormone fails to induce a decrease in IL6 levels in the ischemic cortex 24 h after middle cerebral artery occlusion

nervous system
• with prior treatment with glucocorticoid stress hormone followed by middle cerebral artery occlusion
• prior treatment with glucocorticoid stress hormone fail to exhibit a reduction in numbers of infiltrating monocytes and IL6 protein levels in infarcted hemisphere after middle cerebral artery occlusion unlike in wild-type mice




Genotype
MGI:5803966
cn2
Allelic
Composition
Nr3c1tm2.1Ljm/Nr3c1tm2.1Ljm
Tg(Camk2a-cre)T29-1Stl/0
Genetic
Background
involves: 129S6/SvEvTac * BALB/c * C57BL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr3c1tm2.1Ljm mutation (1 available); any Nr3c1 mutation (35 available)
Tg(Camk2a-cre)T29-1Stl mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
N
• as in wild-type mice, prior treatment with glucocorticoid stress hormone followed by middle cerebral artery occlusion sensitizes neurons to excityotoxicity
• prior treatment with glucocorticoid stress hormone fail to exhibit a reduction in numbers of infiltrating monocytes after middle cerebral artery occlusion unlike in wild-type mice

homeostasis/metabolism
N
• as in wild-type mice, prior treatment with glucocorticoid stress hormone followed by middle cerebral artery occlusion sensitizes neurons to excityotoxicity
• prior treatment with glucocorticoid stress hormone fail to exhibit a reduction in numbers of infiltrating monocytes after middle cerebral artery occlusion unlike in wild-type mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory